Professional Documents
Culture Documents
1
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
Otavio Dantas Julien Imbert
Managing Director and Partner Managing Director and Partner
Today's São Paulo São Paulo
presenters
2
Agenda
COVID-19 evolution update 10 min.
Macro scenarios and micro implications 20 min.
Performance improvement through digitization in response to Covid19 crisis 15 min.
Q&A 15 min.
3
COVID-19 evolution update
4
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
Healthcare
system GDP
capacity
Critical care
patients
Time
5
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
Brazil Early Flatten 31K 8.8% 0.30K 27(50) days (SP) 49%
USA Early Flatten 671K 4.8% 10.26K 28(56) days (NY) 44%
Lockdown lifted Localized lockdown National lockdown New daily cases/deaths decreasing4 …increasing …stable
Note: Authorities in Wuhan have revised its death toll upwards by ~50% from 2,579 to 3,869 in 16 April. As, according to officials, the revision was due to delayed reporting, this information is not considered in the avg. daily growth calculation.
1. Average daily growth of past 4 days, 2. Lockdown durations based on lockdown start date until dashboard update date and until public announced date 3. Data from Google Community Mobility report from April 15 – Isolation index is the
average reduction in mobility compared to a baseline in three areas: Retail & recreation, Transit stations and Workplaces, 4. Compares avg. daily new cases form current week versus previous week
Source: Johns Hopkins CSSE; Press search; IBGE; Google Community Mobility; BCG analysis 6
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
39 (54) days
14/3 25/4
2 weeks lock down Extended to 12/4 Extended to 25/4
34 (42) days
16/3 11/5
2 weeks lock down Extended to 15/4 Extended to 11/05
32 (56) days
23/3 3/5
26 (42) days
16/3 (NY) 29/4 (NY)
Extended to 15/05
28 (56) days
23/3 3/4 7/5
(NY)
Extended to 07/05
25 (45) days
21/3 (SP) 22/4 10/5 (SP)
Extended to 10/05
27 (50) days
(SP)
Exit plan begun Exit plan announced Italy - 9 Mar – 3 May (54 days)
• Bookshops, laundries, stationers, children’s clothes
No plan yet No lockdown in place stores reopened in some regions
• Forestry industry and IT equipment factories
No information workers were been allowed to return to work
• Lombardy still with full lockdown 9
Source: Press search, BCG analysis
BCG Brazil COVID Task Force Backup
bcg.brazil.covid19@bcg.com
Japan Canada
5 UK US
Belgium Cases doubling:
France Spain 14 days
Portugal
Netherlands Iran Italy
South Korea Switzerland China Germany
0
1,000 10,000 100,000 1,000,000 Fight
20
Switzerland
15
Canada Deaths doubling:
5 days
Brazil US
Japan
10
Growth rate
India Germany
Belgium Deaths doubling:
8 days
Netherlands UK
France
5 Portugal
Deaths doubling:
Spain 14 days
Italy
Iran
South Korea China
0
100 1,000 10,000 100,000
20
15
PE Cases doubling:
5 days
Growth rate
10 BA AM
SP
CE Cases doubling:
MG RJ 8 days
RS
5
DF SC Cases doubling:
14 days
PR
0
100 1,000 10,000 100,000
Confirmed cases per state… …with 9% avg. growth in the past 4 days
Cumulative # of cases, by # of days since 10th case (log scale)
100,000
Cases double
…every 3 days …every 4 days
every 2 days
SP
10,000
CE RJ
AM
PE
MG
1,000
ES BA
100
10
0 5 10 15 20 25 30 35 40 45
Number of days1
1. Number of days after exceeding 10 confirmed cases; Source: Ministry of health, BCG analysis 13
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force Backup
bcg.brazil.covid19@bcg.com
Confirmed deaths per state… …with 12% avg. growth in the past 4 days
Cumulative # of deaths, by # of days since 10th case (log scale)
10,000
Deaths double
…every 2 days …every 3 days
every day
1,000 SP
RJ
PE
AM
100 CE
10
1
0 5 10 15 20 25 30
Number of days1
1. Number of days after first death; Source: Ministry of health, BCG analysis 14
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force Backup
bcg.brazil.covid19@bcg.com
Disclaimer: studies suggest that real number of cases in Brazil, and other
countries, is beyond the reported ones
Data as of 14 Apr
3/26 print
Subway 7 on March 17th at 1:30 PM Source: NBER, Department of Labor, and BCG Center for Macroeconomics analysis 17
between Grand Central and Times Square Photo credit: Author
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
A hierarchy of thought
Underlying
epidemiology unclear:
"Relapse until
vaccine in hand" or
"herd immunity"
within reach?
19
Source: Johns Hopkins University, BCG Center for Macroeconomics
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
?
Need serological (antibodies) testing to
determine degree of asymptomatic
In U.S., testing had gotten off to a … though when scaled for the larger Implications for duration of social
slow start, thus no reliable U.S. population it is still insufficient distancing and thus extent of
quantitative baseline. macroeconomic damage
Now moving in right direction…
Source: Covidtracking.com, German Hospital Society (DKG), Korean Center for Disease Control, BCG Center for Macroeconomics 20
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
Lost output
Lost output Lost output
V shape leaves de minimis impact One-off damage to economy's Recurring or irreparable damage to
on the present value of future supply side (capital, labor, economy's supply side leads to
output productivity) leads to more and perpetually growing loss of present
perpetual loss of present value of value of future output
future output
22
Source: BCG Center for Macroeconomics analysis
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
Eventually returns to
trend but can take a
Never comes back to prior
long time
Canada closest to V-shape U.S. clear U-shape (returning to Greece experienced a sustained
(returns to prior trend) growth rate, but at a lower trend) depression and L-shape
No systematic banking crisis – no Driven by severe banking crisis – a Growth has struggled at a much
damage to economy's supply side one time hit to capital formation slower pace, with recurring
(supply side) damage to supply side
Note: Canada trend (1985-2008); US trend (2003-2007); Greece trend (1995-2006) 23
Source: NBER, BEA, Statistics Canada, Hellenic Statistical Authority (ELSTAT), BCG Center for Macroeconomics analysis
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
I.e. "geometry" of the shock: will it be a I.e. "intensity" of the shock, a different
V, U, or L shape and what does it imply dimension from "geometry"
24
Source: BCG Center for Macroeconomics analysis
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
(~0%) 2001
(>6%) V
Trend growth
U L
Trend growth
• 2008 was a severe U shaped recession as
GDP drew down 4% over 6 quarters and
unaffected
2008 recession
downgraded never returned to the prior trend
(-4.0%/6Q)
(~0%) 2001
(>6%) V
Trend growth
U L
Trend growth
geometry of shock risk towards U
The battle to avoid a recession is lost – the
battle for the shape of the shock is not yet
unaffected downgraded
lost
Key question: Can policy prevent a shift to a
Geometry of shock (V-U-L) U shape where potential GDP (level) is
impaired?
26
Source: NBER, BEA, BCG Center for Macroeconomics analysis
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
(~0%) 2001
1991
productivity.
(>6%) V
Trend growth
U L
Trend growth
2. Extended real economy "freeze" which
also damages capital formation
unaffected downgraded
Coronavirus has unique risk profile in that both
paths to structural damage are plausible/likely
Geometry of shock (V-U-L) and are also interdependent
27
Source: BCG Center for Macroeconomics analysis
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
28
Source: BCG Center for Macroeconomics analysis
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
29
Source: BCG Center for Macroeconomics analysis
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
Cons. Confidence Housing and auto sales PMI (manufacturing) PMI new orders
As outlined, have some confidence on drivers of Even as e.g. V-shape plays out at macro level,
shock geometry (strategic call), less so on individual firms could still face U or L scenarios
intensity/duration of shock (tactical call) (e.g. airlines, cruise lines, live entertainment
33
Source: BCG Center for Macroeconomics analysis
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
14% of companies improve growth and margin …and the performance gap
in downturns, while 44% decline in both… between them is substantial
Increasing sales growth
Revenue growth Change in
A (CAGR)2 EBIT margin2
8.8% +14pp
14% 14%
44% 28%
-4.7% -4.4pp
B
Falling sales growth
A B A B
1. Average across last four U.S. downturns since 1986; based on performance compared to three-year pre-downturn baseline for U.S. companies with at least $50M sales 2. Annualized 34
revenue growth during the downturn period 3. Compared to three-year average pre-downturn EBIT margin | Source: S&P Compustat and Capital IQ, BCG Henderson Institute
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
Falling
32% 34% 28%
B growth and 36%
47% 45% 46% 45%
EBIT margin 54% 53%
Avg:
44%
1. Average across last four U.S. downturns since 1986; based on performance compared to three-year pre-downturn baseline for U.S. companies with at least $50M sales 35
Note: Sectors based on GICS definitions | Source: S&P Compustat and Capital IQ, BCG Henderson Institute
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
Performance improvement
through digitization in
response to Covid19 crisis
36
COVID-19 with significant impact on companies – focus so far on
protecting measures, less on business action
1 Analytics driven transparency 1 Push of online channels, distribution, 1 Performance improvement Focus of this
(people, finance, supply chain) inside sales, digital demand through digitization/cost-out deck
2 Analytics and AI simulations 2 Digital marketing & personalization 2 Analytics based reconfiguration
(demand, supply chain, cash, patient finder, (eCommerce) of supply chain
pricing)
Actionable steering cockpit Dynamic supply chain Business model innovation & digital
2.4×
1.8× 1,5×
8.7%
(1) Customer offer & Go-to-market (2) Operations (3) Support functions
(1.1) Research & product development (2.1) Manufacturing (I4.0) (3.1) Corporate center
(1.2) Personalization & Digital marketing (2.2) Digital supply chain (3.2) Shared services & centers of excellence
(4) Changing ways of working (5) Leveraging the power of data & technology
Dimension with short- to mid-term performance impact Enablers supporting relevant PID dimensions
40
There is a long list of performance improvement levers available
# of levers
Domains & dimensions Digital Trad. Total EXAMPLES
(1) Customer offer & Go-to-market 23 16 39
(1.1) Research & product development 5 3 7
(1.2) Personalization & Digital marketing 6 1 7 Reduce customer churn with predictive models
(1.3) Next-generation sales 7 7 14 Up to 3% increase in revenue | 30-50% increased customer retention | 5-10% churn reduction
(1.4) Digitally driven pricing 5 5 10
(2) Operations 32 16 48
(2.1) Manufacturing (I4.0) 10 5 15
(2.2) Digital supply chain 7 4 11 Real-time dashboards for data-driven E2E SC mgmt
(2.3) Procurement 8 3 11 3-5% product cost reduction | 2-5% improvement in customer service | 10-20% lower logistics cost
(2.4) Service operations 7 4 11
41
Example levers on level 2
(2) Operations
Preliminary impact/payback figures collected from KDPs—to be detailed and refined to make them more concrete
6-12 months EBIT 2.2.D2 Build real-time dashboards for data-driven E2E supply chain mgmt. Example
impact:
0-1pp 2.2.D3 Implement dynamic E2E inventory reduction
2.2.D4 Leverage analytical models/simulations for optimizing logistics
Full EBIT impact: 1-2pp network and planning routes & goods mix
2.2.D5 Optimize S&OP (sales and ops planning) with advanced analytics
Revenue uplift: n/a 2.2.D6 Use adv. analytics to improve forecast accuracy & drive
better supply decisions
(2) Operations 2.2.D7 Use linear optimization algorithms to optimize supply networks
Cost reduction: 10-20% SC infrastructure costs 2.2.T1 Optimize logistics spend via load consolidation and efficient
Digital levers: New levers improving performance based on the power of digital, tech, and data
Traditional levers: Proven levers which have been used for many years to improve performance. Levers make use of digital elements as well
42
Note: This deck focuses on digital levers only. The traditional levers have been listed as reference and addressed by TURN Rapid Assessment Toolbox
Companies can expect significant uplift already with 6-12 months ROI
Customer offer & Operations Support Functions Changing ways of Leveraging the
Go-to-Market working power of data &
tech.
6–12 months
0-2pp 0-2pp 0–1pp 0–0.5pp 0–1pp
EBIT impact (pp)
Full mid-term
Revenue
5-15% n/a n/a n/a n/a
uplift (%)
44
Example Vignette / Use case Backup
1. Enterprise resource planning 2. Laboratory information management system 3. Quality management system 4. Manufacturing execution system
5. Enterprise Asset Management Software 6. Electronic batch record 45
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
at LinkedIn BCG.Brazil.Covid19@bcg.com
BCG is helping hundreds of companies around the world to overcome the COVID Reach out to us if your
crisis, to support the society, and to capitalize on emerging opportunities company needs support
46
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
47
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are
advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most recent advice issued by your local (and national) health authorities, before making any decision
bcg.com